Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
Status:
Terminated
Trial end date:
2016-06-27
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect, safety, and tolerability of ceftazidime-avibactam
(CAZ-AVI) plus vancomycin or linezolid compared to standard of care plus vancomycin or
linezolid as empiric therapy in febrile neutropenic adults with cancer
Phase:
Phase 2
Details
Lead Sponsor:
Forest Laboratories
Treatments:
Avibactam Avibactam, ceftazidime drug combination Cefepime Ceftazidime Linezolid Meropenem Penicillanic Acid Piperacillin Piperacillin, Tazobactam Drug Combination Tazobactam Vancomycin